Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)
Price and Volume
Detailed Quote| Volume | 575,356 |
| Open | 0.3800 |
| Bid (Size) | 0.3875 (5,000) |
| Ask (Size) | 0.3943 (300) |
| Prev. Close | 0.3863 |
| Today's Range | 0.3768 - 0.3946 |
| 52wk Range | 0.3030 - 1.629 |
| Shares Outstanding | 137,508,926 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
52-Week Range
76.0% below 52-week high
0.3909
0.3052W Low
1.6352W High
1 Week
20.6% below 1-week high
0.371W Low
0.491W High
Lucid Diagnostics Inc. - Common Stock (LUCD) traded between $0.30 and $1.63 over the past 52 weeks and last traded at $0.39, 76.0% below its 52-week high. Over the past week it ranged between $0.37 and $0.49.
Past 12 Months
1W
-$0.06
1M
+$0.04
3M
-$0.57
6M
-$0.61
YTD
-$0.73
1Y
-$0.63
LUCD was -61.7% over the past year, -60.9% over six months, -65.1% year to date, -13.0% in the last week.
12 Months vs Market
LUCD
-61.7%
DIA
+6.3%
SPY
+6.7%
QQQ
+4.6%
IWM
+12.2%
Over the past 12 months LUCD returned -61.7% versus DIA (Dow) +6.3%, SPY (S&P 500) +6.7%, QQQ (Nasdaq 100) +4.6% and IWM (Russell 2000) +12.2%.
Volume & Liquidity
0.12× 3-mo avg
Today 575,356
3-mo avg 5.0M
1W
2.4M
1M
11.4M
3M
5.0M
6M
3.3M
YTD
2.3M
1Y
2.2M
LUCD most recently traded 575,356 shares against a 3-month average daily volume of 5.0M.
More News
Read More
US Session Top Movers: CLRO and XXII Lead Stock Gainers and Losers ↗
October 26, 2026
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Top US Stock Gainers and Losers in Today's Session ↗
October 23, 2026
Most Active US Stocks: Oct. 23, 2026 Volume Leaders ↗
October 23, 2026
Today's U.S. Session Top Movers: Small-Cap Gainers and Losers ↗
October 23, 2026
Gap-Up and Gap-Down Stocks: October 23, 2026 Session ↗
October 23, 2026
Premarket Movers: October 23, 2026 US Session ↗
October 23, 2026
Postmarket Movers: After-Hours Gainers and Decliners ↗
October 22, 2026
What's going on in today's after hours session ↗
October 01, 2026
Which stocks are experiencing notable movement on Thursday? ↗
October 01, 2026
Lucid Diagnostics (LUCD) Q2 2026 Earnings Call Transcript ↗
August 20, 2026
Lucid Diagnostics Eyes Medicare Catalyst for EsoGuard Growth ↗
August 15, 2026
Lucid Diagnostics Q2 Earnings Call Highlights ↗
August 13, 2026
Lucid Diagnostics Q2 2026 Earnings Call: Complete Transcript ↗
August 13, 2026
PAVmed (PAVM) Q4 2025 Earnings Transcript ↗
May 15, 2026
LUCD Q1 2026 Earnings Transcript ↗
May 14, 2026
Lucid Diagnostics Q1 Earnings Call Highlights ↗
May 14, 2026
Lucid Diagnostics (LUCD) Earnings Transcript ↗
March 26, 2026
Frequently Asked Questions
Is Lucid Diagnostics Inc. - Common Stock publicly traded?
Yes, Lucid Diagnostics Inc. - Common Stock is publicly traded.
What exchange does Lucid Diagnostics Inc. - Common Stock trade on?
Lucid Diagnostics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lucid Diagnostics Inc. - Common Stock?
The ticker symbol for Lucid Diagnostics Inc. - Common Stock is LUCD on the Nasdaq Stock Market
What is the current price of Lucid Diagnostics Inc. - Common Stock?
The current price of Lucid Diagnostics Inc. - Common Stock is 0.3909
When was Lucid Diagnostics Inc. - Common Stock last traded?
The last trade of Lucid Diagnostics Inc. - Common Stock was at 11/20/26 10:59 AM ET
What is the market capitalization of Lucid Diagnostics Inc. - Common Stock?
The market capitalization of Lucid Diagnostics Inc. - Common Stock is 53.75M
How many shares of Lucid Diagnostics Inc. - Common Stock are outstanding?
Lucid Diagnostics Inc. - Common Stock has 54M shares outstanding.